Powder: -20°C for 3 years | In solvent: -80°C for 1 year
T807 (AV-1451) 是新型的tau 正电子发射断层扫描示踪剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 283 | 现货 | ||
2 mg | ¥ 395 | 现货 | ||
5 mg | ¥ 659 | 现货 | ||
10 mg | ¥ 1,120 | 现货 | ||
25 mg | ¥ 1,860 | 现货 | ||
50 mg | ¥ 2,730 | 现货 | ||
100 mg | ¥ 4,120 | 现货 | ||
200 mg | ¥ 5,870 | 现货 | ||
500 mg | ¥ 8,690 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 413 | 现货 |
产品描述 | T807 (AV-1451) is a novel tracer of tau positron emission tomography (PET). |
体外活性 | In vitro autoradiography results show that [18F]T807 exhibits strong binding to PHF-tau positive human brain sections with Kd of 14.6 nM. Comparison of autoradiography and double immunohistochemical staining of adjacent sections of PHF-tau and Ab showed that [18F] T807 binding is colocalized with immunoreactive PHF-tau pathology, but does not highlight Ab plaques[1]. [18F]T807 strongly binds to tau lesions primarily made of paired helical filaments in Alzheimer’s brains e.g. intra and extraneuronal tangles and dystrophic neurites. [18F]T807 off-target binding to neuromelanin- and melanin-containing cells and, to a lesser extent, to brain hemorrhagic lesions is identified[2]. |
体内活性 | [18F]T807 can cross the blood-brain barrier and ished out quickly in mice models. [18F]T807 clears rapidly from the brain, with activity values decreasing from 4.43% ID/g at 5 minutes to 0.62% ID/g at 30 minutes. Kidney elimination is a significant clearance pathway, resulting in a maximum tracer concentration of 14.99% ID/g in the kidneys at 5 minutes, which decreases to 5.52% ID/g at 30 minutes. The accumulation of activity in muscle and bone remain relatively low throughout the PET scan[1]. |
别名 | AV-1451 |
分子量 | 263.27 |
分子式 | C16H10FN3 |
CAS No. | 1415379-56-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 16.6 mg/mL (63.05 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.7984 mL | 18.9919 mL | 37.9838 mL | 94.9595 mL |
5 mM | 0.7597 mL | 3.7984 mL | 7.5968 mL | 18.9919 mL | |
10 mM | 0.3798 mL | 1.8992 mL | 3.7984 mL | 9.496 mL | |
20 mM | 0.1899 mL | 0.9496 mL | 1.8992 mL | 4.748 mL | |
50 mM | 0.076 mL | 0.3798 mL | 0.7597 mL | 1.8992 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
T807 1415379-56-4 Cytoskeletal Signaling Microtubule Associated T-807 AV1451 T 807 Inhibitor AV-1451 inhibit AV 1451 inhibitor